PATENT CLAIM ANALYSIS

Application Number: 15986707
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "021800"]

Abstract:
Described herein are methods of syntheses and therapeutic uses of covalently modified peptides and/or proteins. The covalently modified peptides and/or proteins allow for improved pharmaceutical properties of peptide and protein-based therapeutics.

Claim (Index 48):
A peptide product comprising a surfactant X covalently attached to a peptide, the peptide comprising a linker amino acid U and at least one other amino acid: wherein the surfactant X is wherein:\n A is a hydrophobic group which is a substituted or unsubstituted C 1 -C 30  alkyl group, a substituted or unsubstituted alkoxyaryl group, a substituted or unsubstituted aralkyl group, or a steroid nucleus-containing moiety; and \n B is a hydrophilic group which is a saccharide and is covalently attached to the peptide via the linker amino acid U; \n and wherein the peptide product displays arrestin-biased agonism or antagonism compared to the unmodified peptide not covalently attached to the surfactant X.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 93.0
- Lexical Diversity: 1.375
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14118546', '14646246', '15913845', '14118545', '15820127']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8365752806617055
- 35 USC 102 Novelty (BERT): 0.7019094178239559
- Combined Prediction Score: 0.8231086943779305
- Mean Citation Score: 682.8825220000001
- Max Citation Score: 780.8741
- Similarity Product: 711.9152452984034

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test